Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
Quick Stats
Feb 02, 202661.0
AI Score
BUY0.51
Volume Ratio
Mar 26, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
ABOS Stock Summary
Last updated Feb 02, 2026
ABOS is currently trading at $2.59, positioned above its 200-day moving average of $1.57, indicating a long-term uptrend. The stock has a 52-week range of $0.8551 to $3.0499.
Technical Analysis: The 50-day moving average stands at $2.01, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 66.021, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.255, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABOS at 61.0/100 with a BUY recommendation.
ABOS (Acumen Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 66.021 |
| CMF (20) | -0.255 |
| ROC (10) | 37.037 |
| ADX (14) | 31.01 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.177 |
| AROONOSC (14) | 78.571 |
| WILLAMS %R (14) | -33.45 |
| MFI (14) | 89.109 |
ABOS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ABOS Price vs Max Options Open Interest
ABOS Max Change In Options Open Interest
ABOS Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABOS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABOS Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABOS Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Acumen Pharmaceuticals, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ABOS Moving Averages Analysis
Acumen Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Acumen Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
ABOS (Acumen Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 2.32 |
| 20 | 2.09 |
| 30 | 2.1 |
| 50 | 2.01 |
| 100 | 1.91 |
| 200 | 1.57 |
ABOS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 157.5 million |
| Earnings/Share ($) | -2.21 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.2847 |
| EPS Estimate Next Year ($) | -1.9359 |
| WallStreet Target Price ($) | 7 |
| Most Recent Quarter |